DEF 14A: Definitive information statements
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | PRE 14A: Preliminary proxy statements relating to merger or acquisition
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 8-K: Current report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 10-K: Annual report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 8-K: Current report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(2.9%),Lind Global Partners II LLC(2.9%), etc.
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | SCHEDULE 13G/A: Others
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 8-K: Current report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 424B3: Prospectus
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | EFFECT: Others
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 8-K: Current report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | CORRESP: CORRESP
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | CORRESP: CORRESP
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 8-K: Current report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | 8-K: Current report
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | SC 13G: Statement of acquisition of beneficial ownership by individuals
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | UPLOAD: Others
REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM) | DEF 14A: Definitive information statements
No Data